Kaken signs Stat6 global licensing agreement with Johnson&Johnson
海角七号
发表于 어제 16:13
115
0
0
Japanese pharmaceutical company Kaken announced on December 26th that it has signed a license agreement with Johnson&Johnson for the global development, production, and commercialization of the STAT6 project that Kaken is currently developing. According to the terms of the agreement, Kaken will grant Johnson&Johnson an exclusive license for the global development, production, and commercialization of the STAT6 project, including KP-723 (an oral STAT6 inhibitor in preclinical development). Kaken will advance the completion of Phase I clinical trials for KP-723, after which Johnson&Johnson will conduct clinical development and commercialization worldwide. Kaken will retain its commercial rights in Japan, while Johnson&Johnson can choose to sign a joint promotion agreement with Kaken. Kaken will receive a $30 million advance payment from Johnson&Johnson. Based on development progress and sales milestones, Kaken will be eligible for successful payments of up to $1.2175 billion, as well as lower double-digit global sales royalties.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
You may like
- Global highlights next week: Federal Reserve releases meeting minutes, focusing on gold and Bitcoin trends
- Musk broke the record! The world's first person!
- Cut interest rates! Cut interest rates! Cut interest rates! Global central banks compete to prepare for Trump 2.0
- Global highlights for next week: Super central bank hits hard, Federal Reserve's favorite inflation indicator released
- Is the world's third-largest car company expected to emerge? Honda, Nissan reportedly in talks to merge, Mitsubishi may also join
- Trump reportedly plans to continue supporting Ukraine, US House Republicans reach agreement on spending bill | Global markets
- Are fireflies too ugly? Is it reasonable to compare video speed bumps with ET9? NIO: "Design for the World" and "Extremely Fair"
- Beike terminates its agreement to acquire equity in Space Intelligence
- Global market: Nasdaq returns above 20000 points, Tesla rises more than 7%, Apple hits new high, market value reaches 3.9 trillion yuan
- 2024 US stock market changes, looking back at the top ten events that shook the market | Global year-end inventory
-
월마트의 차세대 매장이 등장하여 우수한 업종을 조정하고 업그레이드하며 업태를 재창조하는 것이 상초매장의 최근 발전 중점이 되었다. 12월 24일, 월마트중국은 신세대 점포인 곤명룡천점과 정대점이 잇달아 12 ...
- 刀与菊滦
- 그저께 19:13
- Up
- Down
- Reply
- Favorite
-
신경보소식 (기자 장결): 12월 24일, 조개지주유한회사는"공간지혜의 모든 남은 주주권을 수매할것을 건의하는것을 중지한다"는 공고를 발표했다.조개지주유한회사의 2023년 10월 11일 공고에 따르면 이 거래는 공 ...
- 清风吹袭断
- 3 일전
- Up
- Down
- Reply
- Favorite
-
금융 서비스 회사인 캔터 피츠제럴드는 AMD의 목표가를 180달러에서 150달러로 낮춰'증액'등급을 유지했다.
- 罗明之星
- 그저께 17:27
- Up
- Down
- Reply
- Favorite
-
"애플이 인공지능에 대대적으로 투자했다: 시가총액이 4조 달러에 육박한다."로이터 통신의 월요일 (12월 23일) 보도에 따르면, 애플은 이 역사적인 평가 경쟁에서 이미 Nvidia와 마이크로소프트를 앞섰다.이 신문 ...
- simple_lynn
- 3 일전
- Up
- Down
- Reply
- Favorite